Lloyd’s gives in-principle approval for MCI drug testing SIAB
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
  • Email
Insurance Insider is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Lloyd’s gives in-principle approval for MCI drug testing SIAB

Asta-managed Syndicate 1966 will target £75mn GWP for 2024.

  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
  • Email
Lloyds building.jpg

Lloyd’s has granted in-principle approval for MCI Syndicate 1966, a syndicate-in-a-box (SIAB) that will offer insurance for clinical trial funding.

The

Enter your e-mail to claim a free trial:

Uncover exclusive insights tailored for insurance leaders

    • Stay Informed: Access exclusive industry insights
    • Gain a competitive advantage: Hear first about tactical developments
    • Make better decisions: Understand market dynamics in crucial lines of business

Topics

Gift this article